2019
DOI: 10.1590/0037-8682-0334-2019
|View full text |Cite
|
Sign up to set email alerts
|

De novo histoid leprosy - Further points of focus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…To date, there is no standard regimen recommended for HL, but the current treatment for multibacillary leprosy can be used for a patient with HL [3, 12, 13]. Recent recommendations for HL comprise screening the patient’s family and chemoprophylaxis, with a single dose of rifampicin, to close contacts [14].…”
Section: Discussionmentioning
confidence: 99%
“…To date, there is no standard regimen recommended for HL, but the current treatment for multibacillary leprosy can be used for a patient with HL [3, 12, 13]. Recent recommendations for HL comprise screening the patient’s family and chemoprophylaxis, with a single dose of rifampicin, to close contacts [14].…”
Section: Discussionmentioning
confidence: 99%